2seventy bio, Inc. (TSVT)
NASDAQ: TSVT · IEX Real-Time Price · USD
4.470
-0.050 (-1.11%)
At close: Jul 19, 2024, 4:00 PM
4.610
+0.140 (3.13%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
2seventy bio Revenue
2seventy bio had revenue of $71.20M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $12.44M. In the year 2023, 2seventy bio had annual revenue of $100.39M with 9.72% growth.
Revenue (ttm)
$71.20M
Revenue Growth
-42.90%
P/S Ratio
3.23
Revenue / Employee
$259,858
Employees
274
Market Cap
229.78M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 100.39M | 8.89M | 9.72% |
Dec 31, 2022 | 91.50M | 36.97M | 67.81% |
Dec 31, 2021 | 54.52M | -193.60M | -78.03% |
Dec 31, 2020 | 248.12M | 203.83M | 460.15% |
Dec 31, 2019 | 44.30M | -10.28M | -18.84% |
Dec 31, 2018 | 54.58M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTSVT News
- 25 days ago - 2seventy bio Announces Sale of Hemophilia A Candidate and MegaTAL In Vivo Gene Editing Technology to Novo Nordisk for up to $40 million - Business Wire
- 2 months ago - 2seventy bio to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - 2seventy bio Reports First Quarter Financial Results and Recent Operational Progress - Business Wire
- 2 months ago - 2seventy bio to Report First Quarter 2024 Financial Results on May 8, 2024 - Business Wire
- 4 months ago - 2seventy bio Announces Completion of Oncology and Autoimmune Pipeline Divestiture to Regeneron - Business Wire
- 4 months ago - 2seventy bio Announces Appointments of Eli Casdin and Charles Newton to Board of Directors - Business Wire
- 4 months ago - 2seventy bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Progress - Business Wire
- 5 months ago - 2seventy bio to Report Fourth Quarter and Full Year 2023 Financial Results and Participate in Upcoming Investor Conferences - Business Wire